These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8467793)

  • 1. Influence of the v-Myb transactivation domain on the oncoprotein's transformation specificity.
    Frampton J; Kouzarides T; Döderlein G; Graf T; Weston K
    EMBO J; 1993 Apr; 12(4):1333-41. PubMed ID: 8467793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. v-Myb DNA binding is required to block thrombocytic differentiation of Myb-Ets-transformed multipotent haematopoietic progenitors.
    Frampton J; McNagny K; Sieweke M; Philip A; Smith G; Graf T
    EMBO J; 1995 Jun; 14(12):2866-75. PubMed ID: 7540977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individual repeats of Drosophila Myb can function in transformation by v-Myb.
    Bin X; Lipsick JS
    J Virol; 1993 Dec; 67(12):7332-9. PubMed ID: 8230457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weak transcriptional activation is sufficient for transformation by v-Myb.
    Engelke U; Whittaker L; Lipsick JS
    Virology; 1995 Apr; 208(2):467-77. PubMed ID: 7747419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Myb leucine zipper is essential for leukemogenicity of the v-Myb protein.
    Bartůnek P; Karafiát V; Dvoráková M; Záhorová V; Mandíková S; Zenke M; Dvorák M
    Oncogene; 1997 Dec; 15(24):2939-49. PubMed ID: 9416837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Definition of functional domains in P135gag-myb-ets and p48v-myb proteins required to maintain the response of neuroretina cells to basic fibroblast growth factor.
    Garrido C; Leprince D; Lipsick JS; Stehelin D; Gospodarowicz D; Saule S
    J Virol; 1992 Jan; 66(1):160-6. PubMed ID: 1727478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The various domains of v-myb and v-ets oncogenes of E26 retrovirus contribute differently, but cooperatively, in transformation of hematopoietic lineages.
    Domenget C; Leprince D; Pain B; Peyrol S; Li RP; Stehelin D; Samarut J; Jurdic P
    Oncogene; 1992 Nov; 7(11):2231-41. PubMed ID: 1331935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA binding by c-Ets-1, but not v-Ets, is repressed by an intramolecular mechanism.
    Lim F; Kraut N; Framptom J; Graf T
    EMBO J; 1992 Feb; 11(2):643-52. PubMed ID: 1311254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A highly conserved cysteine in the v-Myb DNA-binding domain is essential for transformation and transcriptional trans-activation.
    Grässer FA; LaMontagne K; Whittaker L; Stohr S; Lipsick JS
    Oncogene; 1992 May; 7(5):1005-9. PubMed ID: 1570148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TATA-box dependent trans-activation of the human HSP70 promoter by Myb proteins.
    Foos G; Natour S; Klempnauer KH
    Oncogene; 1993 Jul; 8(7):1775-82. PubMed ID: 8510924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myb-Ets fusion oncoprotein inhibits thyroid hormone receptor/c-ErbA and retinoic acid receptor functions: a novel mechanism of action for leukemogenic transformation by E26 avian retrovirus.
    Rascle A; Ferrand N; Gandrillon O; Samarut J
    Mol Cell Biol; 1996 Nov; 16(11):6338-51. PubMed ID: 8887663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the DNA-binding and transcriptional activation domains of v-Myb cooperate in transformation.
    Dini PW; Eltman JT; Lipsick JS
    J Virol; 1995 Apr; 69(4):2515-24. PubMed ID: 7884901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic activation of the chicken mim-1 gene by v-myb and C/EBP transcription factors.
    Burk O; Mink S; Ringwald M; Klempnauer KH
    EMBO J; 1993 May; 12(5):2027-38. PubMed ID: 8491193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic point mutations induce altered conformation, redox sensitivity, and DNA binding in the minimal DNA binding domain of avian myeloblastosis virus v-Myb.
    Brendeford EM; Myrset AH; Hegvold AB; Lundin M; Gabrielsen OS
    J Biol Chem; 1997 Feb; 272(7):4436-43. PubMed ID: 9020167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. tom-1, a novel v-Myb target gene expressed in AMV- and E26-transformed myelomonocytic cells.
    Burk O; Worpenberg S; Haenig B; Klempnauer KH
    EMBO J; 1997 Mar; 16(6):1371-80. PubMed ID: 9135152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fusion of the nuclear oncoproteins v-Myb and v-Ets is required for the leukemogenicity of E26 virus.
    Metz T; Graf T
    Cell; 1991 Jul; 66(1):95-105. PubMed ID: 2070421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excision of Ets by an inducible site-specific recombinase causes differentiation of Myb-Ets-transformed hematopoietic progenitors.
    Rossi F; McNagny KM; Logie C; Stewart AF; Graf T
    Curr Biol; 1996 Jul; 6(7):866-72. PubMed ID: 8805301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The carboxy-terminal domain of c-Myb activates reporter gene expression in yeast.
    Seneca S; Punyammalee B; Sureau A; Perbal B; Dvorák M; Crabeel M
    Oncogene; 1993 Sep; 8(9):2335-42. PubMed ID: 8361752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single amino-acid substitution in the DNA-binding domain of the myb oncogene confers a thermolabile phenotype to E26-transformed myeloid cells.
    Li RP; Duterque-Coquillaud M; Lagrou C; Debuire B; Graf T; Stehelin D; Leprince D
    Oncogene Res; 1989; 5(2):137-41. PubMed ID: 2608278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The v-Rel oncoprotein increases expression from Sp1 site-containing promoters in chicken embryo fibroblasts.
    Sif S; Capobianco AJ; Gilmore TD
    Oncogene; 1993 Sep; 8(9):2501-9. PubMed ID: 8361761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.